Related Experiment Video
Updated: Sep 6, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Promises and challenges: cabotegravir for preexposure prophylaxis
Matthew A Spinelli1, Beatriz Grinsztejn2, Raphael J Landovitz3
1Division of HIV, ID, and Global Medicine, University of California, San Francisco, California, USA.
Injectable cabotegravir-based pre-exposure prophylaxis (PrEP) offers higher HIV prevention effectiveness than daily oral PrEP. Implementation requires addressing challenges like monitoring and accessibility for widespread use.
Area of Science:
- Infectious Diseases
- Public Health
- Pharmacology
Background:
- Oral tenofovir-based pre-exposure prophylaxis (PrEP) has reduced HIV incidence but disparities persist.
- Injectable cabotegravir-based PrEP presents an alternative for individuals with adherence issues or preference against daily medication.
Purpose of the Study:
- To review the efficacy, promises, and challenges of cabotegravir-based PrEP.
- To evaluate cabotegravir's role in expanding HIV prevention options.
Main Methods:
- Review of randomized trials comparing injectable cabotegravir-based PrEP with oral PrEP.
- Analysis of effectiveness data in key populations, including men who have sex with men (MSM), transgender women, and cisgender women in sub-Saharan Africa.
Main Results:
- Cabotegravir demonstrated significantly higher effectiveness in preventing HIV incidence compared to oral PrEP in trials.
- High effectiveness was observed in populations with disproportionate HIV burden, including MSM, transgender women, and cisgender women.
- Rare breakthrough infections with cabotegravir were associated with delayed diagnosis using antigen/antibody tests and rare instances of resistance.
Conclusions:
- Cabotegravir-based PrEP is a highly effective additional option for HIV prevention.
- Successful implementation necessitates developing strategies for streamlined and accessible delivery in real-world settings.
- Challenges include the need for HIV RNA monitoring, additional clinic resources, and managing dosing interruptions.
Related Concept Videos
Retrovirus Life Cycles
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Subviral Agents
Retroviruses
Sexually Transmitted Infections
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

